CBmed brings together scientific experts with leading pharmaceutical, diagnostic, medical-technology and IT industry partners. In addition, CBmed has a strong network in the area of Biobanking including the largest Biobank in Europe, Biobank Graz, and the European Biobanking network BBMRI-ERIC. CBmed research projects will identify new biomarkers, validate potential biomarkers and conduct translational biomarker research for products to be used in clinical practice.
CBmed will develop easily applicable, targeted, minimally invasive biomarkers for better diagnosis, better therapy monitoring and a more personalized treatment of patients.
A company presentation is available for download here.
CBmed Projects aim to develop easily applicable, targeted, minimally invasive biomarkers for better diagnosis, better therapy monitoring and a more personalized treatment of patients.MORE ABOUT ALL PROJECTS AND PARTNERS
Our vision is to become the world's most recognized center for biomarker research in personalized medicine by 2030.
This will be achieved by integrating cutting-edge technologies with international and interdisciplinary expertise in the fields of cancer, metabolism and inflammation.
Together with our scientific and industry partners, we will develop solutions and products for patient care and cure.